WASHINGTON — An advisory panel has urged the Food and Drug Administration to loosen its restrictions on the controversial diabetes drug Avandia, which was nearly wiped from the market in recent years after reports linking it to several heart-related complications.
In a June 6 vote, 13 members of the 26-member » […]
Original post by http://lawyersusaonline.com/blog/2013/06/07/panel-urges-fda-to-loosen-avandia-restrictions/
Report bad drivers!